Advertisement

Frontiers of Medicine

, Volume 10, Issue 2, pp 152–165 | Cite as

Chemical transdifferentiation: closer to regenerative medicine

  • Aining Xu
  • Lin Cheng
Review

Abstract

Cell transdifferentiation, which directly switches one type of differentiated cells into another cell type, is more advantageous than cell reprogramming to generate pluripotent cells and differentiate them into functional cells. This process is crucial in regenerative medicine. However, the cell-converting strategies, which mainly depend on the virus-mediated expression of exogenous genes, have clinical safety concerns. Small molecules with compelling advantages are a potential alternative in manipulating cell fate conversion. In this review, we briefly retrospect the nature of cell transdifferentiation and summarize the current developments in the research of small molecules in promoting cell conversion. Particularly, we focus on the complete chemical compound-induced cell transdifferentiation, which is closer to the clinical translation in cell therapy. Despite these achievements, the mechanisms underpinning chemical transdifferentiation remain largely unknown. More importantly, identifying drugs that induce resident cell conversion in vivo to repair damaged tissue remains to be the end-goal in current regenerative medicine.

Keywords

cell therapy cell transdifferentiation chemical compounds small molecules tissue regeneration 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Waddington CH. The Strategy of the Genes: a Discussion of Some Aspects of Theoretical Biology. London: Allen & Unwin, 1957Google Scholar
  2. 2.
    Xu J, Du Y, Deng H. Direct lineage reprogramming: strategies, mechanisms, and applications. Cell Stem Cell 2015; 16(2): 119–134PubMedCrossRefGoogle Scholar
  3. 3.
    Xu Y, Shi Y, Ding S. A chemical approach to stem-cell biology and regenerative medicine. Nature 2008; 453(7193): 338–344PubMedCrossRefGoogle Scholar
  4. 4.
    Tsonis PA, Madhavan M, Tancous EE, Del Rio-Tsonis K. A newt’s eye view of lens regeneration. Int J Dev Biol 2004; 48(8-9): 975–980PubMedCrossRefGoogle Scholar
  5. 5.
    Tsonis PA, Madhavan M, Call M K, Gainer S, Rice A, Del Rio-Tsonis K. Effects of a CDK inhibitor on lens regeneration. Wound Repair Regen 2004; 12: 24–29PubMedCrossRefGoogle Scholar
  6. 6.
    Hajduskova M, Ahier A, Daniele T, Jarriault S. Cell plasticity in Caenorhabditis elegans: from induced to natural cell reprogramming. Genesis 2012; 50(1): 1–17PubMedCrossRefGoogle Scholar
  7. 7.
    Henry JJ, Thomas AG, Hamilton PW, Moore L, Perry KJ. Cell signaling pathways in vertebrate lens regeneration. Curr Top Microbiol Immunol 2013; 367: 75–98PubMedPubMedCentralGoogle Scholar
  8. 8.
    Tsonis PA, Vergara MN, Spence JR, Madhavan M, Kramer EL, Call MK, Santiago WG, Vallance JE, Robbins DJ, Del Rio-Tsonis K. A novel role of the hedgehog pathway in lens regeneration. Dev Biol 2004; 267(2): 450–461PubMedCrossRefGoogle Scholar
  9. 9.
    Maki N, Martinson J, Nishimura O, Tarui H, Meller J, Tsonis PA, Agata K. Expression profiles during dedifferentiation in newt lens regeneration revealed by expressed sequence tags. Mol Vis 2010; 16: 72–78PubMedPubMedCentralGoogle Scholar
  10. 10.
    Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987; 51(6): 987–1000PubMedCrossRefGoogle Scholar
  11. 11.
    Tapscott SJ, Davis RL, Thayer MJ, Cheng PF, Weintraub H, Lassar AB. MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science 1988; 242(4877): 405–411PubMedCrossRefGoogle Scholar
  12. 12.
    Kulessa H, Frampton J, Graf T. GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes Dev 1995; 9(10): 1250–1262PubMedCrossRefGoogle Scholar
  13. 13.
    Shen CN, Slack JM, Tosh D. Molecular basis of transdifferentiation of pancreas to liver. Nat Cell Biol 2000; 2(12): 879–887PubMedCrossRefGoogle Scholar
  14. 14.
    Heins N, Malatesta P, Cecconi F, Nakafuku M, Tucker KL, Hack MA, Chapouton P, Barde YA, Götz M. Glial cells generate neurons: the role of the transcription factor Pax6. Nat Neurosci 2002; 5(4): 308–315PubMedCrossRefGoogle Scholar
  15. 15.
    Yamanaka S, Takahashi K. Induction of pluripotent stem cells from mouse fibroblast cultures. Protein, Nucleic acid, Enzyme (Tanpakushitsu Kakusan Koso) 2006; 51: 2346–2351 (in Japanese)Google Scholar
  16. 16.
    Heinrich C, Blum R, Gascón S, Masserdotti G, Tripathi P, Sánchez R, Tiedt S, Schroeder T, Götz M, Berninger B. Directing astroglia from the cerebral cortex into subtype specific functional neurons. PLoS Biol 2010; 8(5): e1000373PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Karow M, Sánchez R, Schichor C, Masserdotti G, Ortega F, Heinrich C, Gascón S, Khan MA, Lie DC, Dellavalle A, Cossu G, Goldbrunner R, Götz M, Berninger B. Reprogramming of pericytederived cells of the adult human brain into induced neuronal cells. Cell Stem Cell 2012; 11(4): 471–476PubMedCrossRefGoogle Scholar
  18. 18.
    Kajimura S, Seale P, Kubota K, Lunsford E, Frangioni JV, Gygi SP, Spiegelman BM. Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-beta transcriptional complex. Nature 2009; 460(7259): 1154–1158PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Nam YJ, Song K, Luo X, Daniel E, Lambeth K, West K, Hill JA, DiMaio JM, Baker LA, Bassel-Duby R, Olson EN. Reprogramming of human fibroblasts toward a cardiac fate. Proc Natl Acad Sci USA 2013; 110(14): 5588–5593PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Wada R, Muraoka N, Inagawa K, Yamakawa H, Miyamoto K, Sadahiro T, Umei T, Kaneda R, Suzuki T, Kamiya K, Tohyama S, Yuasa S, Kokaji K, Aeba R, Yozu R, Yamagishi H, Kitamura T, Fukuda K, Ieda M. Induction of human cardiomyocyte-like cells from fibroblasts by defined factors. Proc Natl Acad Sci USA 2013; 110(31): 12667–12672PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Hiramatsu K, Sasagawa S, Outani H, Nakagawa K, Yoshikawa H, Tsumaki N. Generation of hyaline cartilaginous tissue from mouse adult dermal fibroblast culture by defined factors. J Clin Invest 2011; 121(2): 640–657PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Han JK, Chang SH, Cho HJ, Choi SB, Ahn HS, Lee J, Jeong H, Youn SW, Lee HJ, Kwon YW, Cho HJ, Oh BH, Oettgen P, Park YB, Kim HS. Direct conversion of adult skin fibroblasts to endothelial cells by defined factors. Circulation 2014; 130(14): 1168–1178PubMedCrossRefGoogle Scholar
  23. 23.
    Pereira CF, Chang B, Qiu J, Niu X, Papatsenko D, Hendry CE, Clark NR, Nomura-Kitabayashi A, Kovacic JC, Ma’ayan A, Schaniel C, Lemischka IR, Moore K. Induction of a hemogenic program in mouse fibroblasts. Cell Stem Cell 2013; 13(2): 205–218PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Batta K, Florkowska M, Kouskoff V, Lacaud G. Direct reprogramming of murine fibroblasts to hematopoietic progenitor cells. Cell Reports 2014; 9(5): 1871–1884PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Szabo E, Rampalli S, Risueño RM, Schnerch A, Mitchell R, Fiebig-Comyn A, Levadoux-Martin M, Bhatia M. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 2010; 468(7323): 521–526PubMedCrossRefGoogle Scholar
  26. 26.
    Feng R, Desbordes SC, Xie H, Tillo ES, Pixley F, Stanley ER, Graf T. PU.1 and C/EBPα/β convert fibroblasts into macrophage-like cells. Proc Natl Acad Sci USA 2008; 105(16): 6057–6062PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Hendry CE, Vanslambrouck JM, Ineson J, Suhaimi N, Takasato M, Rae F, Little MH. Direct transcriptional reprogramming of adult cells to embryonic nephron progenitors. J Am Soc Nephrol 2013; 24(9): 1424–1434PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Lemper M, Leuckx G, Heremans Y, German MS, Heimberg H, Bouwens L, Baeyens L. Reprogramming of human pancreatic exocrine cells to β-like cells. Cell Death Differ 2015; 22(7): 1117–1130PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Chanda S, Ang CE, Davila J, Pak C, Mall M, Lee QY, Ahlenius H, Jung SW, Südhof TC, Wernig M. Generation of induced neuronal cells by the single reprogramming factor ASCL1. Stem Cell Rep 2014; 3(2): 282–296CrossRefGoogle Scholar
  30. 30.
    Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Südhof TC, Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010; 463(7284): 1035–1041PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Sheng C, Zheng Q, Wu J, Xu Z, Wang L, Li W, Zhang H, Zhao XY, Liu L, Wang Z, Guo C, Wu HJ, Liu Z, Wang L, He S, Wang XJ, Chen Z, Zhou Q. Direct reprogramming of Sertoli cells into multipotent neural stem cells by defined factors. Cell Res 2012; 22(1): 208–218PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Marro S, Pang ZP, Yang N, Tsai MC, Qu K, Chang HY, Südhof TC, Wernig M. Direct lineage conversion of terminally differentiated hepatocytes to functional neurons. Cell Stem Cell 2011; 9(4): 374–382PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Ginsberg M, James D, Ding BS, Nolan D, Geng F, Butler JM, Schachterle W, Pulijaal VR, Mathew S, Chasen ST, Xiang J, Rosenwaks Z, Shido K, Elemento O, Rabbany SY, Rafii S. Efficient direct reprogramming of mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression. Cell 2012; 151(3): 559–575PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Huang P, He Z, Ji S, Sun H, Xiang D, Liu C, Hu Y, Wang X, Hui L. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature 2011; 475(7356): 386–389PubMedCrossRefGoogle Scholar
  35. 35.
    Sekiya S, Suzuki A. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature 2011; 475(7356): 390–393PubMedCrossRefGoogle Scholar
  36. 36.
    Forsberg M, Carlén M, Meletis K, Yeung MS, Barnabé-Heider F, Persson MA, Aarum J, Frisén J. Efficient reprogramming of adult neural stem cells to monocytes by ectopic expression of a single gene. Proc Natl Acad Sci USA 2010; 107(33): 14657–14661PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Corti S, Nizzardo M, Simone C, Falcone M, Donadoni C, Salani S, Rizzo F, Nardini M, Riboldi G, Magri F, Zanetta C, Faravelli I, Bresolin N, Comi GP. Direct reprogramming of human astrocytes into neural stem cells and neurons. Exp Cell Res 2012; 318(13): 1528–1541PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Wang L, Wang L, Huang W, Su H, Xue Y, Su Z, Liao B, Wang H, Bao X, Qin D, He J, Wu W, So KF, Pan G, Pei D. Generation of integration-free neural progenitor cells from cells in human urine. Nat Methods 2013; 10(1): 84–89PubMedCrossRefGoogle Scholar
  39. 39.
    Efe JA, Hilcove S, Kim J, Zhou H, Ouyang K, Wang G, Chen J, Ding S. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat Cell Biol 2011; 13(3): 215–222PubMedCrossRefGoogle Scholar
  40. 40.
    Kurian L, Sancho-Martinez I, Nivet E, Aguirre A, Moon K, Pendaries C, Volle-Challier C, Bono F, Herbert JM, Pulecio J, Xia Y, Li M, Montserrat N, Ruiz S, Dubova I, Rodriguez C, Denli AM, Boscolo FS, Thiagarajan RD, Gage FH, Loring JF, Laurent LC,Izpisua Belmonte JC. Conversion of human fibroblasts to angioblast-like progenitor cells. Nat Methods 2013; 10(1): 77–83PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Li J, Huang NF, Zou J, Laurent TJ, Lee JC, Okogbaa J, Cooke JP, Ding S. Conversion of human fibroblasts to functional endothelial cells by defined factors. Arterioscler Thromb Vasc Biol 2013; 33(6): 1366–1375PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Li K, Zhu S, Russ HA, Xu S, Xu T, Zhang Y, Ma T, Hebrok M, Ding S. Small molecules facilitate the reprogramming of mouse fibroblasts into pancreatic lineages. Cell Stem Cell 2014; 14(2): 228–236PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Zhu S, Rezvani M, Harbell J, Mattis AN, Wolfe AR, Benet LZ, Willenbring H, Ding S. Mouse liver repopulation with hepatocytes generated from human fibroblasts. Nature 2014; 508(7494): 93–97PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Lumelsky N. Small molecules convert fibroblasts into islet-like cells avoiding pluripotent state. Cell Metab 2014; 19(4): 551–552PubMedCrossRefGoogle Scholar
  45. 45.
    Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, Liu L, Conway SJ, Fu JD, Srivastava D. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012; 485(7400): 593–598PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG, Srivastava D. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010; 142(3): 375–386PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to β-cells. Nature 2008; 455(7213): 627–632PubMedCrossRefGoogle Scholar
  48. 48.
    Banga A, Akinci E, Greder LV, Dutton JR, Slack JM. In vivo reprogramming of Sox9+ cells in the liver to insulin-secreting ducts. Proc Natl Acad Sci USA 2012; 109(38): 15336–15341PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Song K, Nam YJ, Luo X, Qi X, Tan W, Huang GN, Acharya A, Smith CL, Tallquist MD, Neilson EG, Hill JA, Bassel-Duby R, Olson EN. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 2012; 485(7400): 599–604PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Torper O, Pfisterer U, Wolf DA, Pereira M, Lau S, Jakobsson J, Björklund A, Grealish S, Parmar M. Generation of induced neurons via direct conversion in vivo. Proc Natl Acad Sci USA 2013; 110(17): 7038–7043PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Niu W, Zang T, Zou Y, Fang S, Smith DK, Bachoo R, Zhang CL. In vivo reprogramming of astrocytes to neuroblasts in the adult brain. Nat Cell Biol 2013; 15(10): 1164–1175PubMedCrossRefGoogle Scholar
  52. 52.
    Rouaux C, Arlotta P. Direct lineage reprogramming of post-mitotic callosal neurons into corticofugal neurons in vivo. Nat Cell Biol 2013; 15(2): 214–221PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Riddell J, Gazit R, Garrison BS, Guo G, Saadatpour A, Mandal PK, Ebina W, Volchkov P, Yuan GC, Orkin SH, Rossi DJ. Reprogramming committed murine blood cells to induced hematopoietic stem cells with defined factors. Cell 2014; 157(3): 549–564PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Ladewig J, Mertens J, Kesavan J, Doerr J, Poppe D, Glaue F, Herms S, Wernet P, Kögler G, Müller FJ, Koch P, Brüstle O. Small molecules enable highly efficient neuronal conversion of human fibroblasts. Nat Methods 2012; 9(6): 575–578PubMedCrossRefGoogle Scholar
  55. 55.
    Liu ML, Zang T, Zou Y, Chang JC, Gibson JR, Huber KM, Zhang CL. Small molecules enable neurogenin 2 to efficiently convert human fibroblasts into cholinergic neurons. Nat Commun 2013; 4: 2183PubMedPubMedCentralGoogle Scholar
  56. 56.
    Kim YJ, Lim H, Li Z, Oh Y, Kovlyagina I, Choi IY, Dong X, Lee G. Generation of multipotent induced neural crest by direct reprogramming of human postnatal fibroblasts with a single transcription factor. Cell Stem Cell 2014; 15(4): 497–506PubMedCrossRefGoogle Scholar
  57. 57.
    Zhu S, Ambasudhan R, Sun W, Kim HJ, Talantova M, Wang X, Zhang M, Zhang Y, Laurent T, Parker J, Kim HS, Zaremba JD, Saleem S, Sanz-Blasco S, Masliah E, McKercher SR, Cho YS, Lipton SA, Kim J, Ding S. Small molecules enable OCT4-mediated direct reprogramming into expandable human neural stem cells. Cell Res 2014; 24(1): 126–129PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Lee JH, Mitchell RR, McNicol JD, Shapovalova Z, Laronde S, Tanasijevic B, Milsom C, Casado F, Fiebig-Comyn A, Collins TJ, Singh KK, Bhatia M. Single transcription factor conversion of human blood fate to NPCs with CNS and PNS developmental capacity. Cell Reports 2015; 11(9): 1367–1376PubMedCrossRefGoogle Scholar
  59. 59.
    Wang H, Cao N, Spencer CI, Nie B, Ma T, Xu T, Zhang Y, Wang X, Srivastava D, Ding S. Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct4. Cell Reports 2014; 6(5): 951–960PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Ifkovits JL, Addis RC, Epstein JA, Gearhart JD. Inhibition of TGFβ signaling increases direct conversion of fibroblasts to induced cardiomyocytes. PLoS ONE 2014; 9(2): e89678PubMedPubMedCentralCrossRefGoogle Scholar
  61. 61.
    Boyd AW, Schrader JW. Derivation of macrophage-like lines from the pre-B lymphoma ABLS 8.1 using 5-azacytidine. Nature 1982; 297(5868): 691–693PubMedCrossRefGoogle Scholar
  62. 62.
    Cheng L, Hu W, Qiu B, Zhao J, Yu Y, Guan W, Wang M, Yang W, Pei G. Generation of neural progenitor cells by chemical cocktails and hypoxia. Cell Res 2014; 24(6): 665–679PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Han YC, Lim Y, Duffieldl MD, Li H, Liu J, Abdul Manaph NP, Yang M, Keating DJ, Zhou XF. Direct reprogramming of mouse fibroblasts to neural stem cells by small molecules. Stem Cells Int 2016; 2016: 4304916PubMedPubMedCentralGoogle Scholar
  64. 64.
    Mirakhori F, Zeynali B, Kiani S, Baharvand H. Brief azacytidine step allows the conversion of suspension human fibroblasts into neural progenitor-like cells. Cell J 2015; 17(1): 153–158PubMedPubMedCentralGoogle Scholar
  65. 65.
    Hu W, Qiu B, Guan W, Wang Q, Wang M, Li W, Gao L, Shen L, Huang Y, Xie G, Zhao H, Jin Y, Tang B, Yu Y, Zhao J, Pei G. Direct conversion of normal and Alzheimer’s disease human fibroblasts into neuronal cells by small molecules. Cell Stem Cell 2015; 17(2): 204–212PubMedCrossRefGoogle Scholar
  66. 66.
    Dai P, Harada Y, Takamatsu T. Highly efficient direct conversion of human fibroblasts to neuronal cells by chemical compounds. J Clin Biochem Nutr 2015; 56(3): 166–170PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Li X, Zuo X, Jing J, Ma Y, Wang J, Liu D, Zhu J, Du X, Xiong L, Du Y, Xu J, Xiao X, Wang J, Chai Z, Zhao Y, Deng H. Smallmolecule-driven direct reprogramming of mouse fibroblasts into functional neurons. Cell Stem Cell 2015; 17(2): 195–203PubMedCrossRefGoogle Scholar
  68. 68.
    Xu H, Wang Y, He Z, Yang H, Gao WQ. Direct conversion of mouse fibroblasts to GABAergic neurons with combined medium without the introduction of transcription factors or miRNAs. Cell Cycle 2015; 14(15): 2451–2460PubMedCrossRefGoogle Scholar
  69. 69.
    Cheng L, Gao L, Guan W, Mao J, Hu W, Qiu B, Zhao J, Yu Y, Pei G. Direct conversion of astrocytes into neuronal cells by drug cocktail. Cell Res 2015; 25(11): 1269–1272PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Zhang L, Yin JC, Yeh H, Ma NX, Lee G, Chen XA, Wang Y, Lin L, Chen L, Jin P, Wu GY, Chen G. Small molecules efficiently reprogram human astroglial cells into functional neurons. Cell Stem Cell 2015; 17(6): 735–747PubMedCrossRefGoogle Scholar
  71. 71.
    Zhang L, Li P, Hsu T, Aguilar HR, Frantz DE, Schneider JW, Bachoo RM, Hsieh J. Small-molecule blocks malignant astrocyte proliferation and induces neuronal gene expression. Differentiation 2011; 81(4): 233–242PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Ghasemi-Kasman M, Hajikaram M, Baharvand H, Javan M. MicroRNA-mediated in vitro and in vivo direct conversion of astrocytes to neuroblasts. PLoS ONE 2015; 10(6): e0127878PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Thoma EC, Merkl C, Heckel T, Haab R, Knoflach F, Nowaczyk C, Flint N, Jagasia R, Jensen Zoffmann S, Truong HH, Petitjean P, Jessberger S, Graf M, Iacone R. Chemical conversion of human fibroblasts into functional Schwann cells. Stem Cell Rep 2014; 3(4): 539–547CrossRefGoogle Scholar
  74. 74.
    Park G, Yoon BS, Kim YS, Choi SC, Moon JH, Kwon S, Hwang J, Yun W, Kim JH, Park CY, Lim DS, Kim YI, Oh CH, You S. Conversion of mouse fibroblasts into cardiomyocyte-like cells using small molecule treatments. Biomaterials 2015; 54: 201–212PubMedCrossRefGoogle Scholar
  75. 75.
    Fu Y, Huang C, Xu X, Gu H, Ye Y, Jiang C, Qiu Z, Xie X. Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails. Cell Res 2015; 25(9): 1013–1024PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Pennarossa G, Maffei S, Campagnol M, Tarantini L, Gandolfi F, Brevini TA. Brief demethylation step allows the conversion of adult human skin fibroblasts into insulin-secreting cells. Proc Natl Acad Sci USA 2013; 110(22): 8948–8953PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Pereyra-Bonnet F, Gimeno ML, Argumedo NR, Ielpi M, Cardozo JA, Giménez CA, Hyon SH, Balzaretti M, Loresi M, Fainstein-Day P, Litwak LE, Argibay PF. Skin fibroblasts from patients with type 1 diabetes (T1D) can be chemically transdifferentiated into insulinexpressing clusters: a transgene-free approach. PLoS ONE 2014; 9(6): e100369PubMedPubMedCentralCrossRefGoogle Scholar
  78. 78.
    Kanoh Y, Tomotsune D, Shirasawa S, Yoshie S, Ichikawa H, Yokoyama T, Mae S, Ito J, Mizuguchi M, Matsumoto K, Yue F, Sasaki K. In vitro transdifferentiation of HepG2 cells to pancreaticlike cells by CCl4, D-galactosamine, and ZnCl2. Pancreas 2011; 40(8): 1245–1252PubMedCrossRefGoogle Scholar
  79. 79.
    Korac A, Cakic-Milosevic M, Ukropina M, Grubic M, Micunovic K, Petrovic V, Buzadzic B, Jankovic A, Vasilijevic A, Korac B. White adipocytes transdifferentiation into brown adipocytes induced by triiodothyronine. In: EMC 2008 14th European Microscopy Congress 1–5 September 2008, Aachen, Germany. Springer-Verlag Berlin Heidelberg, 2008: 123–124Google Scholar
  80. 80.
    Moisan A, Lee YK, Zhang JD, Hudak CS, Meyer CA, Prummer M, Zoffmann S, Truong HH, Ebeling M, Kiialainen A, Gérard R, Xia F, Schinzel RT, Amrein KE, Cowan CA. White-to-brown metabolic conversion of human adipocytes by JAK inhibition. Nat Cell Biol 2015; 17(1): 57–67PubMedPubMedCentralCrossRefGoogle Scholar
  81. 81.
    Ubil E, Duan J, Pillai IC, Rosa-Garrido M, Wu Y, Bargiacchi F, Lu Y, Stanbouly S, Huang J, Rojas M, Vondriska TM, Stefani E, Deb A. Mesenchymal-endothelial transition contributes to cardiac neovascularization. Nature 2014; 514(7524): 585–590PubMedPubMedCentralCrossRefGoogle Scholar
  82. 82.
    Sayed N, Wong WT, Ospino F, Meng S, Lee J, Jha A, Dexheimer P, Aronow BJ, Cooke JP. Transdifferentiation of human fibroblasts to endothelial cells: role of innate immunity. Circulation 2015; 131(3): 300–309PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    Brevini TA, Pennarossa G, Rahman MM, Paffoni A, Antonini S, Ragni G, de Eguileor M, Tettamanti G, Gandolfi F. Morphological and molecular changes of human granulosa cells exposed to 5-azacytidine and addressed toward muscular differentiation. Stem Cell Rev 2014; 10(5): 633–642PubMedCrossRefGoogle Scholar
  84. 84.
    Nie T, Hui X, Gao X, Nie B, Mao L, Tang X, Yuan R, Li K, Li P, Xu A, Liu P, Ding S, Han W, Cooper GJ, Wu D. Conversion of nonadipogenic fibroblasts into adipocytes by a defined hormone mixture. Biochem J 2015; 467(3): 487–494PubMedCrossRefGoogle Scholar
  85. 85.
    Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010; 7(5): 618–630PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Hou P, Li Y, Zhang X, Liu C, Guan J, Li H, Zhao T, Ye J, Yang W, Liu K, Ge J, Xu J, Zhang Q, Zhao Y, Deng H. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 2013; 341(6146): 651–654PubMedCrossRefGoogle Scholar
  87. 87.
    Zhao Y, Zhao T, Guan J, Zhang X, Fu Y, Ye J, Zhu J, Meng G, Ge J, Yang S, Cheng L, Du Y, Zhao C, Wang T, Su L, Yang W, Deng H. A XEN-like state bridges somatic cells to pluripotency during chemical reprogramming. Cell 2015; 163(7): 1678–1691PubMedCrossRefGoogle Scholar
  88. 88.
    Ye J, Ge J, Zhang X, Cheng L, Zhang Z, He S, Wang Y, Lin H, Yang W, Liu J, Zhao Y, Deng H. Pluripotent stem cells induced from mouse neural stem cells and small intestinal epithelial cells by small molecule compounds. Cell Res 2016; 26(1): 34–45PubMedCrossRefGoogle Scholar
  89. 89.
    Long Y, Wang M, Gu H, Xie X. Bromodeoxyuridine promotes fullchemical induction of mouse pluripotent stem cells. Cell Res 2015; 25(10): 1171–1174PubMedPubMedCentralCrossRefGoogle Scholar
  90. 90.
    Li W, Li K, Wei W, Ding S. Chemical approaches to stem cell biology and therapeutics. Cell Stem Cell 2013; 13(3): 270–283PubMedPubMedCentralCrossRefGoogle Scholar
  91. 91.
    Lin T, Wu S. Reprogramming with small molecules instead of exogenous transcription factors. Stem Cells Int 2015; 2015: 794632PubMedPubMedCentralCrossRefGoogle Scholar
  92. 92.
    Chen T, Yuan D, Wei B, Jiang J, Kang J, Ling K, Gu Y, Li J, Xiao L, Pei G. E-cadherin-mediated cell-cell contact is critical for induced pluripotent stem cell generation. Stem Cells 2010; 28(8): 1315–1325PubMedCrossRefGoogle Scholar
  93. 93.
    Feng B, Jiang J, Kraus P, Ng JH, Heng JC, Chan YS, Yaw LP, Zhang W, Loh YH, Han J, Vega VB, Cacheux-Rataboul V, Lim B, Lufkin T, Ng HH. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat Cell Biol 2009; 11(2): 197–203PubMedCrossRefGoogle Scholar
  94. 94.
    Cheng L. Novel strategy for treating neural disease. Sci China Life Sci 2014; 57(9): 947–948PubMedCrossRefGoogle Scholar

Copyright information

© Higher Education Press and Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  1. 1.State Key Laboratory of Medical Genomics, Shanghai Institute of HematologyRuijin Hospital Affiliated to Shanghai Jiao Tong University School of MedicineShanghaiChina

Personalised recommendations